(Q39715470)

14 September 2017

title

Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates. (English)

1 reference

14 September 2017

1 reference

Patti A Groome

1

1 reference

14 September 2017

Susan L Rohland

2

1 reference

14 September 2017

D Robert Siemens

3

1 reference

14 September 2017

Michael D Brundage

4

1 reference

14 September 2017

Jeremy Heaton

5

1 reference

14 September 2017

William J Mackillop

6

1 reference

14 September 2017

language of work or name

English

0 references

publication date

24 February 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

117

1 reference

14 September 2017

issue

17

1 reference

14 September 2017

page(s)

3943-3952

1 reference

Comorbidity independently predicted death in older prostate cancer patients, more of whom died with than from their disease

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Differential prognostic impact of comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Do older men benefit from curative therapy of localized prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Pretreatment predictors of death from other causes in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Cumulative illness rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Measuring comorbidity in older cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Cumulative Illness Rating Scale was a reliable and valid index in a family practice context

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Does a centralized radiotherapy system provide adequate access to care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Guideline for the management of clinically localized prostate cancer: 2007 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

How to measure comorbidity. a critical review of available methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

Cause of death in men diagnosed with prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

The impact of co-morbidity on life expectancy among men with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

A case-cohort design for epidemiologic cohort studies and disease prevention trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

Waiting for radiotherapy in Ontario

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

Computing the Cox model for case cohort designs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

EAU guidelines on prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

Determining cause of death in prostate cancer: are death certificates valid?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

When is a death from prostate cancer not a death from prostate cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25984

7 January 2021

Identifiers

DOI

10.1002/CNCR.25984

1 reference

14 September 2017

1 reference